Insmed (INSM) Profit After Tax (2010 - 2026)

Insmed (INSM) recorded quarterly Profit After Tax of -$163.6 million in Q1 2026, up 50.19% quarter-over-quarter from -$328.5 million in Q4 2025, and up 36.24% on a YoY basis from -$120.1 million in Q1 2025.

Insmed (INSM) Profit After Tax (2010 - 2026) Analysis & Trends

Insmed's Profit After Tax history runs 17 years deep, the most recent figure standing at -$163.6 million for Q1 2026.

  • In Q1 2026, Profit After Tax rose 36.24% year-over-year to -$163.6 million; the TTM figure through Mar 2026 stood at -$1.2 billion (down 16.83% YoY), while the FY2025 annual figure was -$1.3 billion, down 39.73% from the prior year.
  • Profit After Tax was -$163.6 million for Q1 2026 at Insmed, up from -$328.5 million in the prior quarter.
  • In the past five years, Profit After Tax ranged from a high of -$94.6 million in Q1 2022 to a low of -$370.0 million in Q3 2025.
  • Historically, Profit After Tax has averaged -$210.9 million across 5 years, with a median of -$186.1 million in 2023.
  • The sharpest annual moves came in 2023 and 2026: Profit After Tax sank 155.96% in 2023, then surged 36.24% in 2026.
  • A 5-year view of Profit After Tax shows it stood at -$160.1 million in 2022, then retreated by 16.2% to -$186.1 million in 2023, then decreased by 26.6% to -$235.5 million in 2024, then tumbled by 39.45% to -$328.5 million in 2025, then soared by 50.19% to -$163.6 million in 2026.
  • The last three Profit After Tax figures came in at -$163.6 million (Q1 2026), -$328.5 million (Q4 2025), and -$370.0 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PAT (Qtr)
1 Alterity Therapeutics 762,369.55 Bn 762,369.51 Bn - -
2 Belite Bio 55,096.00 Bn 55,096.00 Bn - -26.94 Mn
3 Quantum Biopharma 17,755.80 Bn 17,755.79 Bn - -2.97 Mn
4 Legend Biotech 3,486.00 Bn 3,485.71 Bn 242.10 Mn 30.90 Mn
5 Akari Therapeutics 1,737.42 Bn 1,737.41 Bn - -14.46 Mn
6 Evaxion A 1,551.28 Bn 1,551.26 Bn - -3.63 Mn
7 Psyence Biomedical 227.32 Bn 227.31 Bn - -753,254.00
8 Vertex Pharmaceuticals 110.84 Bn 103.59 Bn 2.59 Bn 1.03 Bn
9 Abivax 91.71 Bn 91.71 Bn - -56.74 Mn
10 Insmed 19.79 Bn 18.57 Bn 258.54 Mn -163.60 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -163.60 Mn
Dec 31, 2025 -328.48 Mn
Sep 30, 2025 -370.02 Mn
Jun 30, 2025 -321.69 Mn
Mar 31, 2025 -256.58 Mn
Dec 31, 2024 -235.55 Mn
Sep 30, 2024 -220.52 Mn
Jun 30, 2024 -300.61 Mn
Mar 31, 2024 -157.09 Mn
Dec 31, 2023 -186.06 Mn
Sep 30, 2023 -158.93 Mn
Jun 30, 2023 -244.81 Mn
Mar 31, 2023 -159.76 Mn
Dec 31, 2022 -160.12 Mn
Sep 30, 2022 -131.15 Mn
Jun 30, 2022 -95.65 Mn
Mar 31, 2022 -94.62 Mn
Dec 31, 2021 -112.98 Mn
Sep 30, 2021 -112.71 Mn
Jun 30, 2021 -117.32 Mn